United Therapeutics (UTHR) Net Equity Issued and Repurchased (2009 - 2026)
United Therapeutics (UTHR) posted Net Equity Issued and Repurchased of $126.3 million for Q2 2026, up 597.8% from $18.1 million a year earlier and up 84.9% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at United Therapeutics was $333.8 million, up 259.3% year-over-year; for FY2025, it was $173.9 million, up 14.0% from FY2024.
- Annual Net Equity Issued and Repurchased has increased for six consecutive years, with a five-year compound annual growth rate of 38.8% (FY2020 to FY2025).
- In prior years, United Therapeutics' Net Equity Issued and Repurchased was $152.5 million in FY2024 (+55.6%), $98 million in FY2023 (+10.9%), $88.4 million in FY2022 (+76.8%) and $50 million in FY2021 (+47.9%).
- The Q2 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased in data going back to Q3 2009.
- On a year-over-year basis, Net Equity Issued and Repurchased has increased in each of the last four quarters, with growth averaging 243.8% over the last eight quarters.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q4 2022, with growth of 620.8%; the weakest was Q4 2023, with a decline of 86.8%.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $68.3 million (Q1 2026), $99 million (Q4 2025) and $40.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | United Therapeutics | 23.13 Bn | 12.62 Bn | 683.80 Mn | 126.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 126.30 Mn |
| Mar 31, 2026 | 68.30 Mn |
| Dec 31, 2025 | 99.00 Mn |
| Sep 30, 2025 | 40.20 Mn |
| Jun 30, 2025 | 18.10 Mn |
| Mar 31, 2025 | 16.60 Mn |
| Dec 31, 2024 | 25.70 Mn |
| Sep 30, 2024 | 32.50 Mn |
| Jun 30, 2024 | 52.10 Mn |
| Mar 31, 2024 | 42.20 Mn |
| Dec 31, 2023 | 7.30 Mn |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 24.70 Mn |
| Mar 31, 2023 | 61.40 Mn |
| Dec 31, 2022 | 55.50 Mn |
| Sep 30, 2022 | 4.70 Mn |
| Jun 30, 2022 | 23.90 Mn |
| Mar 31, 2022 | 4.30 Mn |
| Dec 31, 2021 | 7.70 Mn |
| Sep 30, 2021 | 14.00 Mn |
API Access
United Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();